Global Cowden Syndrome Market Status, Growth Analysis, Marketing Industry Chain, Size, Share, Regions
Global Cowden Syndrome Market Research Report: By Site (Breast, Thyroid, Colorectal, Kidney, Skin), Treatment (Genetic Testing, Chemotherapy, Targeted Therapy, Surgery & Radiation Therapy, Hormone Therapy), End User (Hospital & Clinics) - Forecast till 2023
Market Highlights
Cowden syndrome is part of the PTEN hamartoma tumor syndrome. Cowden syndrome is characterized by a high risk of both benign and cancerous tumors of the breast, thyroid, endometrium, colorectal, kidney, and skin. The global Cowden syndrome market is expecting a healthy growth in the coming future. The global market is majorly driven by increasing Cowden syndrome patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval and side effects of the treatment may hinder the growth of the market.
Intended Audience
- Pharmaceutical Companies
- Government and private research companies
- Research and Development (R&D) Companies
- Drug Manufacturers and Suppliers
- Medical Research Laboratories
Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/5096
The global Cowden syndrome market is expected to grow at a CAGR of 6.7% during the forecast period 2017-2023.
Segmentation
The global Cowden syndrome market is segmented on the basis of the site, treatment, and end users.
On the basis of the site, the market is segmented into the breast, thyroid, endometrium (uterus), colorectal, kidney, skin (melanoma), and others.
On the basis of the treatment, the market is categorized into genetic testing, chemotherapy, surgery & radiation therapy, targeted therapy, hormone therapy, biologic therapy, and other. The chemotherapy is further segmented into anthracyclines, taxanes, antimetabolites, and alkylating agents. The targeted therapy is sub-segmented with monoclonal antibodies and tyrosine kinase inhibitors. The hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others.
On the basis of the end users, the market is segmented into hospital & clinics, ambulatory care centers, and others.
Regional Analysis
The Americas dominate the global market owing to a huge patient population, high health care spending, and strong government support for research & development. As per the report of the Centers for Disease Control and Prevention, in 2014, over 14.1 million of new cancer cases were registered worldwide. Thus, increasing prevalence of the syndrome has boosted the American market growth. Additionally, changing lifestyle and growing smoking addiction has fuelled the growth of the market.
Europe is the second leading region in the global Cowden syndrome market, which is followed by the Asia Pacific. Germany and the U.K are expected to lead the market of Europe. The Asia Pacific is the fastest growing Cowden syndrome market. Asia Pacific Cowden syndrome market is majorly driven by Japan, India, and China owing to a huge patient pool, and rapidly developing healthcare sector. The Middle East and Africa contribute the least to the growth of the global market. The Middle East holds the major share of the Middle East and African region. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East Cowden syndrome market. However, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region. On the other hand, the growth of the African market is high due to the presence of ample opportunities for the development of the market
Key Players
Some of key the players in the market are Novartis AG (Switzerland), GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Amgen, Inc. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K.), Bristol-Myers Squibb Company (U.S.), Sanofi (France), AbbVie Inc. (U.S.), Spectrum Pharmaceuticals Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.), Immunomedics (U.S.), and Oncomed Pharmaceuticals (U.S.).
Access Report Details @ https://www.marketresearchfuture.com/reports/cowden-syndrome-market-5096
The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
TOC:
- Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
TOC…Continued
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/5096
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Comments
Post a Comment